Lantheus Holdings Inc LNTH

US Health Care

$99.64 ▼ -1.35% ($-1.36)

📅 Earnings This Week

Open $101.03

Prev Close $101.00

Day Range $98.81 – $101.03

52W Range $47.25 – $111.86

Market Cap $6.49B

P/E (TTM) 23.34

Beta -0.01

EPS (TTM) $4.14

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2015-06-25
Shares Out.	65,110,000
Website	lantheus.com/ ↗
Phone	18009279800
Employees	1,193
Revenue	$377.3M
Gross Profit	$230.9M
Net Income	$118.4M
Free Cash Flow	$377.1M
Total Assets	$2.35B
Total Liabilities	$1.13B
Equity	$1.21B

About Lantheus Holdings Inc

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Lantheus Holdings Inc is a publicly traded company under the ticker symbol LNTH on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.